Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update on cabozantinib alone or with atezolizumab for locally advanced or metastatic solid tumors; the study lists mu…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology [NA]
A completed clinical trial evaluating whether therapeutic patient education can reduce the toxicity associated with immune checkpoint inhibi…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for SNS-101 (anti-VISTA) as monotherapy and in combination with cemiplimab in adults with advanced solid tumors, cur…
-
CLINICAL_TRIALS withdrawal · 2025-08-13Clinical Trial Update: Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases [Phase 2]
This Phase 2 trial of lenvatinib plus pembrolizumab in immune-refractory metastatic renal cell carcinoma with brain metastases has been with…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study
A multicenter development/validation study constructs and tests a CT radiomics-derived nomogram to predict early renal function decline afte…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
A clinical trial is evaluating radiomics-based AI models to predict outcomes in renal cell carcinoma patients after surgery. The study is cu…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Clinical Study of a Novel Humanized CD70-Targeted CAR-T Cell Incorporating TLR2 for Advanced Renal Cell Carcinoma Therapy [EARLY_Phase 1]
An early-phase study evaluating a novel humanized CD70-targeted CAR-T cell therapy incorporating TLR2 for advanced renal cell carcinoma; rec…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases [Phase 2]
Phase 2 trial evaluating cabozantinib in metastatic renal cell carcinoma with brain metastases has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) [Phase 2]
Phase 2 study UNICAB evaluating cabozantinib in various non-clear cell renal cell carcinoma subtypes after immunotherapy has been completed.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma [NA]
Clinical trial update evaluating the use of the radiolabeled antibody 124I-cG250 for early detection of response to therapy in metastatic re…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for TRK-950 in combination with anti-cancer regimens in patients with advanced solid tumors; the study is active but no…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer [Phase 2]
A Phase 2 clinical trial is evaluating stereotactic body radiotherapy (SBRT) in combination with ipilimumab and nivolumab for metastatic ren…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating HS-10516 combination therapy in patients with advanced renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2
A prospective evaluation of an AI-based patient stratification tool for renal immuno-oncology in metastatic renal cell carcinoma has been te…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers [NA]
A multi-cancer prospective study evaluating double-positive circulating cells (CD45+ tumor marker) in several types of metastatic cancers; r…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: SAbR For Oligometastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating stereotactic ablative radiotherapy for oligometastatic renal cell carcinoma is currently active but not recruitin…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors [Phase 1]
Phase 1 study evaluating DS-6000a in adults with advanced renal cell carcinoma and ovarian cancer; the trial is currently active but not rec…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating IBR854 plus pazopanib versus pazopanib alone in advanced renal cell carcinoma; status is not yet recruitin…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC) [NA]
A completed clinical trial evaluating serial ultrasound in metastatic renal cell carcinoma has posted results as of July 25, 2025.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma [Phase 1]
This Phase 1 clinical trial is evaluating the combination of MEDI5752 and Axitinib in adults with advanced renal cell carcinoma.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03) [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update evaluating immune and targeted combination therapies in second-line plus renal cell carcinoma (MK-…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment
The ARMOR study registry describes ablation of renal masses and its impact on quality of life, sponsored by Memorial Sloan Kettering Cancer …
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study [Phase 2]
Phase 2 clinical trial evaluating genetic testing to guide therapy for advanced or metastatic renal cell carcinoma.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell [Phase 1]
Phase 1 study evaluating 111In-XYIMSR-01 for SPECT/CT imaging in patients with metastatic renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…